Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|November 22, 2021
Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic AbnormalitiesCarmen-Mariana Aanei, Richard Veyrat-Masson, Cristina Selicean, et al.
Oncotarget|July 14, 2020
Influence of major <i>BCR-ABL1</i> transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinibAlexis Genthon, Franck Emmanuel Nicolini, Françoise Huguet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2016
An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid LeukemiaFrançoise Solly, Catherine Koering, Aminetou Mint Mohamed, et al.
Hemasphere|November 22, 2021
Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French ExperienceAnne Sophie Alary, Carole Maute, Olivier Kosmider, et al.
Leukemia|April 24, 2025
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?Nicolas Gazeau, David Beauvais, Rémi Tilmont, et al.
Leukemia|July 17, 2024
Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO studyCorentin Orvain, Sarah Bertoli, Pierre Peterlin, et al.
Leukemia Research|May 21, 2025
Treatment-free remission in chronic myeloid leukemia with rare ABL1 gene fusions: Real-life study from the French CML group Fi-LMCHyacinthe Johnson-Ansah, Aude Charbonnier, Gabriel Etienne, et al.
Oncotarget|August 19, 2015
Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)Aminetou Mint Mohamed, Marie Balsat, Morgan Thenoz, et al.
Blood Advances|October 17, 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemiaRomane Joudinaud, Augustin Boudry, Laurène Fenwarth, et al.
European Journal of Human Genetics : EJHG|October 3, 2025
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriersMarie-Charlotte Villy, Youenn Drouet, Lise Larcher, et al.
Pageof 3